Soligenix, Inc. SEC filings SNGX

Soligenix, Inc. has 1,006 filings in SEC EDGAR's recent list, going back to Dec 3, 2008. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (bylaw or fiscal year change, shareholder vote results, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Aug 3, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders May 5, 2025 Dec 31, 2024
10-K Annual report Mar 21, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2024 Dec 31, 2023
ARS Annual report to shareholders Aug 7, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K Annual report Mar 26, 2019 Dec 31, 2018
10-K/A Amended annual report Aug 17, 2018 Dec 31, 2017
10-K Annual report Mar 15, 2018 Dec 31, 2017
10-K Annual report Mar 27, 2017 Dec 31, 2016
10-K Annual report Mar 24, 2016 Dec 31, 2015
10-K Annual report Mar 25, 2015 Dec 31, 2014
10-K Annual report Mar 26, 2014 Dec 31, 2013
10-K/A Amended annual report Jun 12, 2013 Dec 31, 2012
10-K Annual report Feb 26, 2013 Dec 31, 2012
10-K Annual report Mar 27, 2012 Dec 31, 2011
10-K Annual report Mar 30, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 30, 2009 Dec 31, 2008

Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SNGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
812796
Former names
SOLIGENIX, INC. (until Nov 6, 2026); DOR BIOPHARMA INC (until Sep 29, 2009); ENDOREX CORP (until Oct 24, 2001); IMMUNOTHERAPEUTICS INC (until Apr 30, 1996)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.